Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 247 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-08-18 | 2023-09-15 | 202409 |
APO-FOSINOPRIL | 20MG | TABLET | Resolved | 2023-10-06 | 2024-02-16 | 206582 |
APO-LENALIDOMIDE | 20MG | CAPSULE | Resolved | 2023-10-20 | 2023-12-01 | 207695 |
APO-ARIPIPRAZOLE | 20MG | TABLET | Resolved | 2023-11-10 | 2023-12-01 | 209898 |
APO-ARIPIPRAZOLE | 20MG | TABLET | Resolved | 2023-11-10 | 2023-12-01 | 209916 |
APO-BACLOFEN | 20MG | TABLET | Resolved | 2023-11-17 | 2023-12-22 | 210677 |
APO-TADALAFIL PAH | 20MG | TABLET | Resolved | 2023-11-24 | 2023-12-22 | 211478 |
APO-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2023-12-15 | 2024-01-05 | 213553 |
APO-ATORVASTATIN | 20MG | TABLET | Resolved | 2023-12-15 | 2024-04-05 | 213556 |
APO-ENALAPRIL | 20MG | TABLET | Resolved | 2023-12-15 | 2023-12-22 | 213562 |
APO-OLMESARTAN | 20MG | TABLET | Actual shortage | 2024-01-19 | 2024-05-10 | 216711 |
APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2024-02-09 | 2024-03-01 | 219144 |
APO-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-02-09 | 2024-04-19 | 219180 |
APO-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-02-16 | 2024-04-05 | 219840 |
APO-FLUOXETINE | 20MG | CAPSULE | Resolved | 2024-02-23 | 2024-03-01 | 220453 |
APO-FLUOXETINE | 20MG | CAPSULE | Resolved | 2024-02-26 | 2024-03-01 | 220650 |
APO-BACLOFEN | 20MG | TABLET | Resolved | 2024-03-15 | 2024-05-24 | 222455 |
HEARTBURN CONTROL | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-03-15 | 2024-04-05 | 222461 |
APO-FUROSEMIDE | 20MG | TABLET | Resolved | 2024-03-22 | 2024-04-19 | 223067 |
APO-FOSINOPRIL | 20MG | TABLET | Resolved | 2024-03-27 | 2024-04-26 | 223558 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60249 |
APO NAPROXEN TAB 125MG | 125MG | TABLET | Discontinued | 2018-09-08 | 2019-08-08 | 60663 |
APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
APO-NIZATIDINE | 150MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1127 |
APO-SULIN TAB 150MG | 150mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1186 |
APO-CLINDAMYCIN | 150MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-28 | 60396 |
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60726 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2019-01-02 | 2019-01-09 | 70810 |
ACID REDUCER | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71210 |
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
APO-CLINDAMYCIN | 150MG | CAPSULE | Discontinued | 2019-11-11 | 2019-11-11 | 98363 |
APO-OXAZEPAM | 15MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60678 |
APO-TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
APO-PINDOL TAB 15MG | 15MG | TABLET | Discontinued | 2022-02-09 | 2022-12-09 | 154574 |
APO-SOTALOL | 160MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4971 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |